Activation of α4β2*/α6β2* nicotinic receptors alleviates anxiety during nicotine withdrawal without upregulating nicotinic receptors.
about
Ion channels gated by acetylcholine and serotonin: structures, biology, and drug discoveryAttenuation of Compulsive-Like Behavior Through Positive Allosteric Modulation of α4β2 Nicotinic Acetylcholine Receptors in Non-Induced Compulsive-Like MiceNicotine modulation of fear memories and anxiety: Implications for learning and anxiety disorders.ABT-089, but not ABT-107, ameliorates nicotine withdrawal-induced cognitive deficits in C57BL6/J mice.Administration of the nicotinic acetylcholine receptor agonists ABT-089 and ABT-107 attenuates the reinstatement of nicotine-seeking behavior in rats.Nicotinic receptor contributions to smoking: insights from human studies and animal modelsEffects of the BDNF Val66Met Polymorphism on Anxiety-Like Behavior Following Nicotine Withdrawal in Mice.Chronic treatment with varenicline changes expression of four nAChR binding sites in mice.Alpha7 nicotinic receptors as therapeutic targets for Parkinson's disease.Nicotine Addiction and Psychiatric Disorders.Substance use modulates stress reactivity: Behavioral and physiological outcomes.Neuropeptide CART prevents memory loss attributed to withdrawal of nicotine following chronic treatment in mice.Pharmacological modulation of the α7 nicotinic acetylcholine receptor in a mouse model of mecamylamine-precipitated nicotine withdrawal.Activation of AMPK by metformin improves withdrawal signs precipitated by nicotine withdrawal.
P2860
Q26799689-E9984CD7-D68E-4D43-83E8-CB395BCA4133Q28468423-2DBFD03E-4D57-4A5B-BABF-6A5CCE425D3BQ30372354-175E7A39-9FF7-4778-B1A5-88399DE6F739Q30386914-987D1EA4-0045-40BD-85F5-647D3268C6A6Q34266602-642FFC81-2616-4F98-B63D-8F6312CBD639Q35966896-EC2009B3-AEC8-4A2F-BFA4-FE69B61D6BFEQ36303874-FB7D4662-9907-4771-AB5B-90ABF739A01AQ36304857-E8BF3B83-4D8A-4CAE-A126-445BCE8775D4Q38532889-ADAE55D0-81A9-4C66-B966-1EF77C59FF83Q38608639-9C01C032-E80D-4C93-90DD-BB234DCA45CFQ38747433-5D61CEA6-77BE-49DA-97C6-D4CD1310B24BQ48201472-7E7D8D83-CFEA-4D15-A07E-B30E6C594B70Q53432314-AF8C7567-E2DC-4394-9EF7-286479DF7484Q55346933-74416C42-5295-47F8-9CB7-11CB675B3BD2
P2860
Activation of α4β2*/α6β2* nicotinic receptors alleviates anxiety during nicotine withdrawal without upregulating nicotinic receptors.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 March 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Activation of α4β2*/α6β2* nico ...... egulating nicotinic receptors.
@en
Activation of α4β2*/α6β2* nico ...... egulating nicotinic receptors.
@nl
type
label
Activation of α4β2*/α6β2* nico ...... egulating nicotinic receptors.
@en
Activation of α4β2*/α6β2* nico ...... egulating nicotinic receptors.
@nl
prefLabel
Activation of α4β2*/α6β2* nico ...... egulating nicotinic receptors.
@en
Activation of α4β2*/α6β2* nico ...... egulating nicotinic receptors.
@nl
P2093
P2860
P356
P1476
Activation of α4β2*/α6β2* nico ...... egulating nicotinic receptors.
@en
P2093
Jill R Turner
Julie A Blendy
Nicole L Yohn
P2860
P304
P356
10.1124/JPET.113.211706
P407
P577
2014-03-13T00:00:00Z